Nanoemulsion Market
Global Nanoemulsion Market: Snapshot
There are various ways in which established players are trying to increase their stronghold over the global market for Nanoemulsion. Expanding outreach in developing markets that offer enormous opportunities to grow is one of them. Besides, they also have a strong pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases.
There are many factors currently boosting the global Nanoemulsion market. Some of them are the technological progress in the pharmaceutical and biotechnology industry, rising instances of chronic diseases, increasing awareness about their treatments, growing demand for more target specific drug delivery systems, and supportive policies of governments. New product launches is also proving to be immensely beneficial for the market.
The other factors responsible for the growth in the market include higher allocations for healthcare infrastructure, rising economic stability, and increasing participation of major market players in in developing economies such as Latin America and the Middle East and Africa.
On account of the aforementioned growth drivers, a report by Transparency Market Research projects the global Nanoemulsion market to rise at a healthy 9.2% CAGR from 2017 and 2025 to become worth US$14.91 bn by 2025 from US$6.78 bn in 2016.
Immunosuppressant See Maximum Uptake
The global market for Nanoemulsion can be segmented based on different parameters. Depending upon the type of drugs, for example, it can be segmented into steroids, anesthetics, NSAIDs, antiretroviral, antimicrobials, vasodilators, immunosuppressant, etc. Of them, the segment of NSAIDs is slated to outpace all others vis-à-vis growth rate by registering a CAGR of 10.1% from 2017 to 2025. This is because of the rising use Nanoemulsion formulation in topical and other drug administration routes for more effective drug delivery allowing for rapid penetration. In terms of market share, however, the segment of immunosuppressant lead the way with 21.3% share in the global Nanoemulsion market in 2016.
Emphasis on Product Development Drives North America Market
From a geographical perspective, North America at present dominates the global Nanoemulsion market. By expanding at a CAGR of 9.3%, the region is expected to pull in a revenue of US$5.96 bn in 2025. The dominant position of the region is a result of a well-established pharmaceutical and biotechnology industry, thrust on research activities for product development, and increasing prevalence of chronic disorders. Europe trails North America vis-à-vis market share. The revenue in the region is predicted to grow to US$5.217 by 2025.
While Europe and North America are dominant in the Nanoemulsion market in terms of size, Asia Pacific will likely run the show when it comes to growth pace by clocking the maximum CAGR of 9.4% during period between 2017 and 2025. The changing demographics and the increasing incomes of people in the region, particularly in the densely populated countries of China and India, are serving to drive growth in the region.
Latin America is another region that is projected to emerge as a profitable on account of governments’ initiatives to promote pharmaceutical and healthcare industries and the increasing healthcare expenditure. The Middle East and Africa Nanoemulsion market, on the other hand, is expected to grow because of the increasing number of products and initiatives by governments to promote research and development.
Prominent participants operating in the global market for Nanoemulsion are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG.
Nanoemulsion Market is witnessing notable revenues due to Major Adoption by Personal Care Industry
There are different strategies by which set up players are attempting to build their fortress over the worldwide market for nanoemulsion. Extending effort in creating markets that offer huge chances to develop is one of them. Plus, they additionally have a solid pipeline of nanoemulsion based antibodies against flu, Bacillus anthracis, chlamydia contamination, a few explicitly communicated contaminations, and respiratory infections.
There are numerous elements as of now boosting the worldwide nanoemulsion market. Some of them are the innovative advancement in the drug and biotechnology industry, rising occurrences of constant sicknesses, expanding mindfulness about their therapies, developing interest for more objective explicit medication conveyance frameworks, and steady approaches of governments.
New item dispatches are likewise ending up being monstrously advantageous for the market.
Nanoemulsion can break up enormous measure of hydrophobics combined with capacity of shielding drugs from cycles, for example, hydrolysis and enzymatic debasement make them ideal transporter. The few benefits of nanoemulsion over ordinary emulsion including miniature bead size of nanoemulsion with higher proficiency as a superior transporter. The previously mentioned factors are driving development of the worldwide nanoemulsion market.
Various driving factors such as fast innovative advances in the field of drugs and biotechnology industry, expanding mindfulness about persistent sicknesses and accessibility of therapies are emphatically impacting development of the worldwide nanoemulsion market. Moreover, various government approaches preferring the objective explicit medications conveyance frameworks are boosting appropriation of target explicit medication conveyance frameworks which is fuelling development of the worldwide nanoemulsion market. Dispatch of mechanically progressed items to satisfy the need for effective medication conveyance frameworks is decidedly affecting on a development of the worldwide nanoemulsion market.
Nonetheless, fabricating cost of nanoemulsion is controlling development of the worldwide nanoemulsion market. By the by, different headways like the no impacts of flocculation and sedimentation, and non-harmful nature makes them reasonable to be utilized in excellence items and infant care items like creams and salves. The appropriation from individual consideration industry has set out rewarding open doors for central participants in the worldwide nanoemulsion market for development and high income age.
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section-2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global Nanoemulsion Market: Market Snapshot
3.2 Global Nanoemulsion Market: Opportunity Map
Section-4 Market Overview
4.1 Global Nanoemulsion Market: Product Overview
4.2 Global Nanoemulsion Market: Key Industry Developments
Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.3 Restraints
5.1.4 Opportunity
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Nanoemulsion Market Revenue Forecast
5.5 Porter’s Five Forces Analysis
5.6 PEST Analysis
5.7 Value Chain Analysis
5.8 Global Nanoemulsion Market Outlook
Section-6 Global Nanoemulsion Market Analysis, by Drug Class
6.1 Key Findings
6.2 Introduction
6.3 Global Nanoemulsion Market Value Share Analysis, by Drug Class
6.4 Global Nanoemulsion Market Forecast, by Drug Class
6.4.1 Steroids
6.4.2 Aesthetics
6.4.3 NSAIDs
6.4.4 Immunosuppressant
6.4.5 Antiretroviral
6.4.6 Antimicrobials
6.4.7 Vasodilators
6.4.8 Others
6.5 Global Nanoemulsion Market Attractiveness Analysis, By Drug Class
Section-7 Global Nanoemulsion Market Analysis, by Route of Administration
7.1 Key Findings
7.2 Introduction
7.3 Global Nanoemulsion Market Value Share Analysis, by Route of Administration
7.4 Market Value (US$ Mn) Forecast By Route of Administration
7.4.1 Topical
7.4.2 Oral
7.4.3 Parenteral
7.4.4 Nasal
7.4.5 Others
7.5 Global Nanoemulsion Market Attractiveness Analysis, By Route of Administration
Section-8 Global Nanoemulsion Market Analysis, by Distribution Channel
8.1 Key Findings
8.2 Introduction
8.3 Global Nanoemulsion Market Value Share Analysis, by Distribution Channel
8.4 Market Value (US$ Mn) Forecast By Distribution Channel
8.4.1 Hospital Pharmacies
8.4.2 Retail Pharmacies
8.4.3 E-Commerce
8.5 Global Nanoemulsion Market Attractiveness Analysis, By Distribution Channel
Section-9 Global Nanoemulsion Market Analysis, by Region
9.1 Geographical Scenario
9.2 Introduction
9.3 Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025
9.4 Nanoemulsion Market Forecast, by Region
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.1 Middle East & Africa
9.5. Nanoemulsion Market Attractiveness Analysis, By Region, 2017 and 2025
Section-10 North America Nanoemulsion Market Analysis and Forecast
10.1 Key Findings
10.2 Market Value (US$ Mn) Forecast, By Country
10.2.1 U.S.
10.2.2 Canada
10.3 Market Value (US$ Mn) Forecast By Drug Class
10.4 Market Value (US$ Mn) Forecast By Route of Administration
10.5 Market Value (US$ Mn) Forecast By Distribution Channel
10.6 Market Attractiveness Analysis
10.6.1 By Country
10.6.2 By Drug Class
10.6.3 By Route of Administration
10.6.4 By Distribution Channel
Section-11 Europe Nanoemulsion Market Analysis and Forecast
11.1 Key Findings
11.2 Market Value (US$ Mn) Forecast, By Country
11.2.1 Germany
11.2.2 France
11.2.3 U.K.
11.2.4 Spain
11.2.5 Italy
11.2.6 Rest of Europe
11.3 Market Value (US$ Mn) Forecast By Drug Class
11.4 Market Value (US$ Mn) Forecast By Route of Administration
11.5 Market Value (US$ Mn) Forecast By Distribution Channel
11.6 Market Attractiveness Analysis
11.4.1 By Country
11.4.2 By Drug Class
11.4.3 By Route of Administration
11.4.4 By Distribution Channel
Sectin-12 Asia Pacific Nanoemulsion Market Analysis and Forecast
12.1 Key Findings
12.2 Market Value (US$ Mn) Forecast, By Country
12.2.1 China
12.2.2 Japan
12.2.3 India
12.2.4 Australia
12.2.5 Rest of APAC
12.3 Market Value (US$ Mn) Forecast By Drug Class
12.4 Market Value (US$ Mn) Forecast By Route of Administration
12.5 Market Value (US$ Mn) Forecast By Distribution Channel
12.6 Market Attractiveness Analysis
12.4.1 By Country
12.4.2 By Drug Class
12.4.3 By Route of Administration
12.4.4 By Distribution Channel
Section-13 Latin America Nanoemulsion Market Analysis and Forecast
13.1 Key Findings
13.2 Market Value (US$ Mn) Forecast, By Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of LATAM
13.2.5 Rest of APAC
13.3 Market Value (US$ Mn) Forecast By Drug Class
13.4 Market Value (US$ Mn) Forecast By Route of Administration
13.5 Market Value (US$ Mn) Forecast By Distribution Channel
13.6 Market Attractiveness Analysis
13.4.1 By Country
13.4.2 By Drug Class
13.4.3 By Route of Administration
13.4.4 By Distribution Channel
Section-14 Latin America Nanoemulsion Market Analysis and Forecast
14.1 Key Findings
14.2 Market Value (US$ Mn) Forecast, By Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 Rest of MEA
14.3 Market Value (US$ Mn) Forecast By Drug Class
14.4 Market Value (US$ Mn) Forecast By Route of Administration
14.5 Market Value (US$ Mn) Forecast By Distribution Channel
14.6 Market Attractiveness Analysis
14.4.1 By Country
14.4.2 By Drug Class
14.4.3 By Route of Administration
14.4.4 By Distribution Channel
Section-15 Competition Landscape
15.1 Global Nanoemulsion Market Share Analysis, by Company (2016)
15.2 Competition Matrix
15.3 Company profiles
15.3.1 AbbVie Inc.
15.3.1.1 Company Details
15.3.1.2 Business Overview
15.3.1.3 Financial Overview
15.3.1.4 Strategic Overview
15.3.1.5 SWOT Analysis
15.3.2 Allergan plc.
15.3.2.1 Company Details
15.3.2.2 Business Overview
15.3.2.3 Financial Overview
15.3.2.4 Strategic Overview
15.3.2.5 SWOT Analysis
15.3.3 AstraZeneca
15.3.3.1 Company Details
15.3.3.2 Business Overview
15.3.3.3 Financial Overview
15.3.3.4 Strategic Overview
15.3.3.5 SWOT Analysis
15.3.4 Fresenius Kabi AG
15.3.4.1 Company Details
15.3.4.2 Business Overview
15.3.4.3 Financial Overview
15.3.4.4 Strategic Overview
15.3.4.5 SWOT Analysis
15.3.5 Kaken Pharmaceutical Co., Ltd.
15.3.5.1 Company Details
15.3.5.2 Business Overview
15.3.5.3 Financial Overview
15.3.5.4 Strategic Overview
15.3.5.5 SWOT Analysis
15.3.6 Mitsubishi Tanabe Pharma Corporation
15.3.6.1 Company Details
15.3.6.2 Business Overview
15.3.6.3 Financial Overview
15.3.6.4 Strategic Overview
15.3.6.5 SWOT Analysis
15.3.7 NanoBio Corporation
15.3.7.1 Company Details
15.3.7.2 Business Overview
15.3.7.3 Financial Overview
15.3.7.4 Strategic Overview
15.3.7.5 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Details
15.3.8.2 Business Overview
15.3.8.3 Financial Overview
15.3.8.4 Strategic Overview
15.3.8.5 SWOT Analysis
15.3.9 GlaxoSmithKline plc.
15.3.9.1 Company Details
15.3.9.2 Business Overview
15.3.9.3 Financial Overview
15.3.9.4 Strategic Overview
15.3.9.5 SWOT Analysis
15.3.10 Sanofi
15.3.10.1 Company Details
15.3.10.2 Business Overview
15.3.10.3 Financial Overview
15.3.10.4 Strategic Overview
15.3.10.5 SWOT Analysis
15.3.11 B. Braun Melsungen AG
15.3.11.1 Company Details
15.3.11.2 Business Overview
15.3.11.3 Financial Overview
15.3.11.4 Strategic Overview
15.3.11.5 SWOT Analysis
List of Tables
Table 01: List of Commercially Available Nanoemulsion
Table 02: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 03: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 04: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 05: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 07: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 08: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 09: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Europe Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 11: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 12: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 13: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 14: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 16: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 17: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Latin America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 19: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 20: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 21: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 22: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 25: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes